ArfGAP Domain-Containing Protein 2 (ADAP2) Integrates Upstream and Downstream Modules of RIG-I Signaling and Facilitates Type I Interferon Production

Mol Cell Biol. 2017 Mar 1;37(6):e00537-16. doi: 10.1128/MCB.00537-16. Print 2017 Mar 15.

Abstract

Transcription of type I interferon genes during RNA virus infection requires signal communication between several pattern recognition receptor (PRR)-adaptor complexes located at distinct subcellular membranous compartments and a central cytoplasmic TBK1-interferon regulatory factor 3 (IRF3) kinase-transcription factor module. However, how the cell integrates signal transduction through spatially distinct modules of antiviral signaling pathways is less defined. RIG-I is a major cytosolic PRR involved in the control of several RNA viruses. Here we identify ArfGAP domain-containing protein 2 (ADAP2) as a key novel scaffolding protein that integrates different modules of the RIG-I pathway, located at distinct subcellular locations, and mediates cellular antiviral type I interferon production. ADAP2 served to bridge the mitochondrial membrane-bound upstream RIG-I adaptor MAVS and the downstream cytosolic complex of NEMO (regulatory subunit of TBK1), TBK1, and IRF3, leading to IRF3 phosphorylation. Furthermore, independently, ADAP2 also functioned as a major orchestrator of the interaction of TBK1 with NEMO and IRF3. Mutational and in vitro cell-free reconstituted RIG-I signaling assay-based analyses identified that the ArfGAP domain of ADAP2 mediates the interferon response. TRAF3 acted as a trigger for ADAP2 to recruit RIG-I pathway component proteins into a single macromolecular complex. This study provides important novel insights into the assembly and integration of different modules of antiviral signaling cascades.

Keywords: RIG-I; innate immunity; interferons.

MeSH terms

  • Cell-Free System
  • DEAD Box Protein 58 / metabolism*
  • GTPase-Activating Proteins / chemistry*
  • GTPase-Activating Proteins / genetics
  • GTPase-Activating Proteins / metabolism*
  • HEK293 Cells
  • Humans
  • Interferon Regulatory Factor-3 / metabolism
  • Interferon Type I / biosynthesis*
  • Interferon Type I / genetics
  • Models, Biological
  • NF-kappa B / metabolism
  • Phosphorylation / drug effects
  • Protein Binding / drug effects
  • Protein Domains
  • Receptors, Immunologic
  • Receptors, Pattern Recognition / metabolism
  • Recombinant Proteins / pharmacology
  • Signal Transduction* / drug effects
  • Subcellular Fractions / metabolism
  • Transcription, Genetic / drug effects
  • Vesiculovirus / physiology

Substances

  • ADAP2 protein, human
  • GTPase-Activating Proteins
  • Interferon Regulatory Factor-3
  • Interferon Type I
  • NF-kappa B
  • Receptors, Immunologic
  • Receptors, Pattern Recognition
  • Recombinant Proteins
  • RIGI protein, human
  • DEAD Box Protein 58

Grants and funding